{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:43:09Z","timestamp":1790930589647,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.autrev.2011.10.021","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T05:03:25Z","timestamp":1319691805000},"page":"596-603","source":"Crossref","is-referenced-by-count":96,"title":["Autoantibodies in lupus: Culprits or passive bystanders?"],"prefix":"10.1016","volume":"11","author":[{"given":"Ole P.","family":"Rekvig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin S.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.10.021_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2010.09.006","article-title":"Systemic lupus erythematosus and the SLE galaxy","volume":"10","author":"Meroni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.autrev.2010.08.016","article-title":"Systemic lupus erythematosus: clinical presentations","volume":"10","author":"Smith","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0015","article-title":"Autoantibody diagnostics in clinical practice","author":"Conrad","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2010.09.007","article-title":"Updating on the pathogenesis of systemic lupus erythematosus","volume":"10","author":"Gualtierotti","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1681\/ASN.2008010112","article-title":"Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes","volume":"20","author":"Mortensen","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2353\/ajpath.2008.070563","article-title":"Lupus nephritis: the central role of nucleosomes revealed","volume":"172","author":"Mortensen","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.10739","article-title":"Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms?","volume":"48","author":"Rekvig","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2011.04.032","article-title":"Epidemiology and management of refractory lupus nephritis","volume":"10","author":"Pons-Estel","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/icb.2010.75","article-title":"Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB\u00d7NZW) F1 mice","volume":"89","author":"Fismen","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0050","doi-asserted-by":"crossref","first-page":"e8474","DOI":"10.1371\/journal.pone.0008474","article-title":"Anti-dsDNA antibodies promote initiation, and acquired loss of renal DNase1 promotes progression of lupus nephritis in autoimmune (NZB\u00d7NZW)F1 mice","volume":"4","author":"Fenton","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2011.10.021_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2353\/ajpath.2009.080943","article-title":"Progression of murine lupus nephritis is linked to acquired renal DNase1 deficiency and not to up-regulated apoptosis","volume":"175","author":"Seredkina","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.ki.5002133","article-title":"Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis","volume":"71","author":"Kalaaji","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2011.10.021_bb0065","doi-asserted-by":"crossref","first-page":"e12096","DOI":"10.1371\/journal.pone.0012096","article-title":"Renal DNase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis","volume":"5","author":"Zykova","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2011.10.021_bb0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2004060494","article-title":"Cisplatin nephrotoxicity is mediated by deoxyribonuclease I","volume":"16","author":"Basnakian","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0075","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10495-010-0478-8","article-title":"Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players","volume":"15","author":"Kruse","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.autrev.2011.10.021_bb0080","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/ard.2007.070482","article-title":"Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis","volume":"66","author":"Mjelle","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.10.021_bb0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0961203308100512","article-title":"Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis","volume":"18","author":"Fismen","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.021_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-065X.2007.00572.x","article-title":"Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity","volume":"220","author":"Krieg","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0095","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.21622","article-title":"Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis","volume":"54","author":"Kalaaji","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0100","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.30211","article-title":"Heparin exerts a dual effect on lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin-binding in glomerular membranes","volume":"63","author":"Hedberg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0105","series-title":"Systemic lupus erythematosus","first-page":"639","article-title":"The central nervous system in systemic lupus erythematosus","author":"Bluestein","year":"1992"},{"key":"10.1016\/j.autrev.2011.10.021_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/berh.2001.0223","article-title":"Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE)","volume":"16","author":"Hermosillo-Romo","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0889-1591(92)90048-S","article-title":"A behavioral profile of autoimmune lupus-prone MRL mice","volume":"6","author":"Sakic","year":"1992","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2011.10.021_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/brbi.1994.1001","article-title":"Behavior and immune status of MRL mice in the postweaning period","volume":"8","author":"Sakic","year":"1994","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2011.10.021_bb0125","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2011.10.021_bb0135","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2011.10.021_bb0140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0031-9384(93)90319-B","article-title":"Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice","volume":"54","author":"Sakic","year":"1993","journal-title":"Physiol Behav"},{"key":"10.1016\/j.autrev.2011.10.021_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2008.11.009","article-title":"Depression is an early disease manifestation in lupus-prone MRL\/lpr mice","volume":"207","author":"Gao","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.10.021_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2010.07.020","article-title":"Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice","volume":"229","author":"Gao","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"ACR ad hoc committee on neuropsychiatric lupus nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0165","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.10.021_bb0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0175","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1073\/pnas.83.19.7419","article-title":"Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus","volume":"83","author":"Elkon","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.10.021_bb0180","first-page":"854","article-title":"Autoantibodies to ribosomal P proteins in systemic lupus erythematosus","volume":"3","author":"Ghirardello","year":"2001","journal-title":"IMAJ"},{"key":"10.1016\/j.autrev.2011.10.021_bb0185","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/ard.59.12.975","article-title":"Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with the IgG anticardiolipin antibodies","volume":"59","author":"Ghirardello","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.10.021_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2010.08.014","article-title":"SLE diagnosis and treatment: when early is early","volume":"10","author":"Doria","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.autrev.2010.09.002","article-title":"Antibodies to ribosomal P proteins in lupus nephritis: a surrogate marker for a better renal survival?","volume":"10","author":"de Macedo","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus psychosis and anti-ribosomal P protein antibodies","volume":"217","author":"Bonfa","year":"1987","journal-title":"N Eng J Med"},{"key":"10.1016\/j.autrev.2011.10.021_bb0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.23218","article-title":"Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis","volume":"58","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","article-title":"Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus","volume":"54","author":"Karassa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/jaut.2002.0595","article-title":"Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays","volume":"19","author":"Ghirardello","year":"2002","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.10.021_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/CVI.13.1.77-83.2006","article-title":"International multicenter evaluation of autoantibodies to ribosomal P proteins","volume":"13","author":"Mahler","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0225","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0961203309353914","article-title":"Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies","volume":"19","author":"Ghirardello","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.021_bb0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.12.002","article-title":"Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study","volume":"32","author":"Briani","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.10.021_bb0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.autrev.2006.07.004","article-title":"Clinical and biological aspects of anti-P-ribosomal protein autoantibodies","volume":"6","author":"Toubi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.10.021_bb0240","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.10.021_bb0245","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 16","key":"10.1016\/j.autrev.2011.10.021_bb0255","first-page":"S23","article-title":"International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations","volume":"14","author":"Tincani","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0260","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.10.021_bb0265","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: \u03b22-Glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.10.021_bb0270","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/art.22522","article-title":"Some antiphospholipid antibodies recognize conformational epitopes shared by \u03b2 2-glycoprotein I and the homologous catalytic domains of several serine proteases","volume":"56","author":"Lin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.021_bb0275","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0961203310361488","article-title":"Some antiphospholipid antibodies bind to various serine proteases in hemostasis and tip the balance toward hypercoagulant states","volume":"19","author":"Chen","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.021_bb0280","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1182\/blood-2005-01-0404","article-title":"Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-beta2-glycoprotein I monoclonal antibodies","volume":"106","author":"Safa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.10.021_bb0285","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1365-2141.2002.03928.x","article-title":"Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome","volume":"119","author":"Takeuchi","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0290","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2000-9808","article-title":"Effects of \u03b22-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis","volume":"26","author":"Ieko","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.autrev.2011.10.021_bb0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","article-title":"Impaired fibrinolysis in the anthiphospholipid syndrome","volume":"12","author":"Krone","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2011.10.021_bb0300","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2007.11.014","article-title":"Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity","volume":"30","author":"Meroni","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.10.021_bb0305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00002281-200109000-00006","article-title":"Pathogenic mechanism mediating antiphospholipid syndrome","volume":"13","author":"Meroni","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0310","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1182\/blood-2004-05-1708","article-title":"Annexin A2 mediates endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies","volume":"105","author":"Zhang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.10.021_bb0315","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0961203309360810","article-title":"Role of tissue factor in thrombosis in antiphospholipid antibody syndrome","volume":"19","author":"Boles","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.021_bb0320","first-page":"51","article-title":"Effect of anticardiolipin\/\u03b22-glycoprotein I antibodies complexes on production of thromboxane A2 by platelet from patients with the antiphospholipid syndrome","volume":"25","author":"Robbins","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.10.021_bb0325","doi-asserted-by":"crossref","first-page":"33831","DOI":"10.1074\/jbc.M212655200","article-title":"Dimers of \u03b22-glycoprotein I increase platelet deposition to collagen via interaction with phospholipid and the apolipoprotein E receptor 2'","volume":"278","author":"Lutters","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2011.10.021_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2002-05-1310","article-title":"Thrombogenicity of \u03b22-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster","volume":"101","author":"Jankowsky","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.10.021_bb0335","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu409oa","article-title":"Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer","volume":"12","author":"Shoenfeld","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.021_bb0340","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-510X(98)00027-6","article-title":"Anti-\u03b22-glycoprotein I antibodies bind to central nervous system","volume":"156","author":"Caronti","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2011.10.021_bb0345","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/ard.2010.142042","article-title":"Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study","volume":"70","author":"Ruffatti","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.10.021_bb0350","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.10.021_bb0355","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.10.021_bb0360","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2010.137281","article-title":"Anti-\u03b22-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune disease preferentially target domain 4\/5: might it be the reason for their \u201cinnocent\u201d profile?","volume":"70","author":"Andreoli","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T05:22:51Z","timestamp":1543468971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1568997211002412"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.10.021","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}